explore -WSS

explore

author：leisure time 2025-09-07 06:43:46 - browse：416

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Inside the fall of star MIT scientist David Sabatini

hotspot

explore

WSS

Option Care buys Amedisys in $3.6 billion home care deal

Van's Gluten Free Original Waffles recalled for possible wheat allergen

A new study asks: Are we harming blood donors by taking blood?

New case study details death in closely watched Alzhiemer's trial

Australia's humpback populations rebound raising hopes of marine scientists

Brain 'hot spot' may explain why African Americans feel greater pain

focus

explore

explore

Tori Bowie and the unacceptable rates of Black maternal death

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

The cancer drug shortage isn’t new — and neither are the solutions

What American doctors can learn from their Israeli counterparts

DIEP, the 'gold standard' of breast reconstruction, is under threat

Make 'food is medicine' a key part of White House nutrition meeting

Cancer drug shortages should be causing more outrage

Did the public have the right to know Arthur Ashe had AIDS?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medicaid rebukes states for mistakenly disenrolling children

focus

Why is France rioting? What to know about the fatal police shooting of Nahel M

Covid hospitalizations on the rise, Humana says

The 10 drugs up first for Medicare price negotiation

The 10 drugs up first for Medicare price negotiation

Weighted lottery helped low

7 people shot in DC, police say

focus

hotspot

explore

focus